Cat.#: ACPP-1339
| Despition | MRAP2 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1754 | Human VEGFC Protein, Sf9 (AC1754) | 2 µg | inquiry |
| ACPP-1524 | Human TARDBP (1-414) Protein (AC1524) | 5 µg | inquiry |
| ACPP-1845 | Human GBA Protein (AC1845) | 2 µg | inquiry |
| ACPP-1113 | Native Porcine GFAP Protein (AC1113) | 25 µl | inquiry |
| ACPP-1368 | KCNJ2 Blocking Peptide (AC1368) | 250 µg | inquiry |
| ACPP-1554 | Human Human FGF1 (Active) Protein (AC1554) | 500U | inquiry |
| ACPP-1144 | Synthetic Nanodisc Human GIPR Protein (AC1144) | 10 µg | inquiry |
| ACPP-1177 | Recombinant Human Prostate Specific Antigen Protein (6×His Tag) (AC1177) | 50 µg | inquiry |
| ACPP-1730 | Human S100A8 Protein, His (AC1730) | 2 µg | inquiry |
| ACPP-1236 | SOX2 Blocking Peptide (AC1236) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.